Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

351

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

July 26, 2021

Study Completion Date

October 20, 2021

Conditions
Acute Kidney Injury (AKI)
Interventions
DRUG

ASP1128

Intravenous Infusion

DRUG

Placebo

Intravenous Infusion

Trial Locations (27)

21804

Delmarva Heart, LLC, Salisbury

26506

WVU Heart and Vascular Institute, Morgantown

27401

Moses H. Cone Memorial Hospital, Greensboro

27710

Duke University Medical Center, Durham

32610

Shands Hospital, Gainesville

33613

Florida Hospital Pepin Heart Institute, Tampa

33756

Morton Plant Hospital, Clearwater

33908

Health Park Medical Center, Fort Myers

35801

Heart Center Research, LLC, Huntsville

37232

Vanderbilt University, Nashville

39202

Baptist Medical Center, Jackson

43606

ProMedica Toledo Hospital, Toledo

44111

Fairview Hospital - Cleveland Clinic, Cleveland

46202

IU Health - Methodist, Indianapolis

46290

St. Vincent Heart Center, Indianapolis

46804

Luthern Medical Group, Fort Wayne

47303

Indiana University Health Ball Memorial Hospital, Muncie

48439

Ascension Genesys Hospital, Grand Blanc

48670

Mid Michigan Medical Center, Midland

50314

MercyOne Iowa Heart Center, Des Moines

55407

Minneapolis Heart Institute, Minneapolis

62794

Southern Illinois University, Springfield

64111

St. Luke's Hospital of Kansas City, Kansas City

75093

Baylor Scott & White Heart Hospital, Plano

78229

University of Texas Health Science Center, San Antonio

85724

Sarver Heart Center, Tucson

08035

Lourdes Cardiology Services, Voorhees Township

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT03941483 - Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery | Biotech Hunter | Biotech Hunter